QRISK2 scores at baseline and after 12 months of follow-up
| Control arm | Intervention arm | |||
|---|---|---|---|---|
| Baseline | 12-month follow-up, adjusted for baseline | Baseline | 12-month follow-up, adjusted for baseline | |
| QRISK2 score for males | 31.59 | 32.00 | 31.83 | 31.60 |
| QRISK2 score for females | 27.73 | 28.24 | 27.86 | 27.84 |
The data are presented as levels of QRISK2 as it is the level of risk that determines the probability of events such as stroke or acute myocardial infarction.
These data are based on imputed QRISK2 scores—multiply imputed data are used in the base case economic evaluation at 12 months from randomisation.3 These data are based on CVD risk of all of those randomised (n=641) in the RCT. The methods used for multiple imputation are described in further detail in the companion 12-month economic evaluation paper.12